The Medical Case for Convenience

Convenience Isn't Separate From Your Medical Care. It is Your Medical Care.

Your physician isn’t gatekeeping your access to infusion therapy—they’re evaluating your clinical appropriateness. If you’re a reasonable candidate, the answer is usually yes.

The Stakes for Each Medication

IVIG [ Intravenous Immunoglobulin (Antibodies) ]

Immunoglobulin levels decline predictably between doses. When you delay treatment, you extend time below the protective threshold. You create a window of vulnerability.

Infliximab
Your body may develop antibodies that neutralize the medication. Once antibodies form, they don’t go away. You may lose the medication entirely—not to side effects, but to missed doses.
VYEPTI

Quarterly dosing builds efficacy through consistency. Postponed infusions don’t just delay prevention—they often trigger breakthrough attacks worse than baseline.

The Barriers That Become Clinical Problems

When infusion days no longer require hours of travel, time off work, and waiting room delays —

patients show up. Consistently. On schedule.
The convenience of home infusion isn’t a luxury feature. It’s a clinical intervention that improves the probability of treatment success by removing the barriers that undermine consistency.